19.04.2013 17:43:00

SCA: SCA’s Divestments of Former Georgia-Pacific Units Approved

Regulatory News:

In conjunction with SCA’s (STO:SCAA) (STO:SCAB) acquisition of Georgia-Pacific’s European tissue operations during the summer of 2012, the EU Commission imposed requirements concerning the divestment of certain units within consumer tissue. This was communicated in a press release on July 19, 2012. The EU Commission has now approved the divestments.

The requirements imposed by the EU Commission included the sale of parts of Georgia-Pacific’s former operations in the UK, Ireland and the Benelux countries, and certain operations in the Scandinavian region.

The branded business in the UK, Ireland and the Benelux countries is being sold to Sofidel. The production facility in Horwich, UK, is included in this transaction.

The retailer brand businesses in the UK and Ireland are being sold to Northwood & WEPA. The production facility in Bridgend, UK, is included in this transaction.

Parts of the Nordic retailer brand business have been sold to Vajda Papir. The production facility in Drammen, Norway is included in the transaction, together with a conversion line from the facility in Nokia, Finland.

These operations together represent total sales of about EUR 200m and the combined purchase consideration is approximately EUR 100m.

SCA is a leading global hygiene and forest products company. The Group develops and produces sustainable personal care, tissue and forest products. Sales are conducted in about 100 countries under many strong brands, including the leading global brands TENA and Tork, and regional brands, such as Lotus, Libresse, Tempo and Libero. As Europe’s largest private forest owner, SCA places considerable emphasis on sustainable forest management. The Group has about 36,000 employees and sales in 2012 amounted to SEK 85bn (EUR 9.8bn). SCA was founded in 1929, has its headquarters in Stockholm, Sweden, and is listed on NASDAQ OMX Stockholm. For more information, visit www.sca.com.

This information was brought to you by Cision http://news.cision.com

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

OMXS PI 964,58 -0,15%